| An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer (NCT05454488) | M.D. Anderson Cancer Center | 2022-07-25 |
| The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors (NCT05131815) | Cedars-Sinai Medical Center | 2022-07-25 |
| Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection (NCT05413850) | Blue Earth Therapeutics Ltd | 2022-07-20 |
| Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study) (NCT05043012) | M.D. Anderson Cancer Center | 2022-07-18 |
| Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer (NCT05313815) | University Health Network, Toronto | 2022-07-18 |
| The Effect of the Educatıon and Counselıng of Prostatectomy Patıents (NCT05428098) | Cukurova University | 2022-07-10 |
| A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer (NCT05361902) | Erasmus Medical Center | 2022-07-07 |
| Head-to-head Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007 (NCT05079828) | Insel Gruppe AG, University Hospital Bern | 2022-07-07 |
| Project CADENCE (CAncer Detected Early caN be CurEd) (NCT05633342) | MiRXES Pte Ltd | 2022-07-07 |
| Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System (NCT05437679) | Angle plc | 2022-07-05 |
| Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate Cancer (NCT04278261) | Shanghai East Hospital | 2022-07-01 |
| Promoting Shared-decision Making in Opportunistic Screening for Prostate Cancer (NCT05187949) | Universidad Miguel Hernandez de Elche | 2022-07-01 |
| Quantitative mpMRI to Predict Metastatic Potential of Prostate Cancer (NCT05252806) | Radboud University Medical Center | 2022-07-01 |
| A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer (NCT05430737) | West China Hospital | 2022-06-30 |
| Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) (NCT05403177) | University Health Network, Toronto | 2022-06-23 |
| A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate Cancer (NCT05416996) | Memorial Sloan Kettering Cancer Center | 2022-06-05 |
| Acupuncture Versus Sham Acupuncture or Usual Care for Antiandrogen-Induced Hot fLashes in Prostate Cancer (AVAIL) (NCT05069467) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2022-06-01 |
| 99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer (NCT06219746) | Turku University Hospital | 2022-06-01 |
| Prostate Metabolism, Cancer Risk and Gut Microbiota (NCT06116851) | Turku University Hospital | 2022-06-01 |
| PROSAIC-DS Study (PROState AI in Cancer - Decision Support) (NCT05355727) | Guy's and St Thomas' NHS Foundation Trust | 2022-06-01 |
| Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy. (NCT05553327) | Hospital Clinic of Barcelona | 2022-05-31 |
| Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) (NCT05345444) | Weill Medical College of Cornell University | 2022-05-26 |
| Study of Prostate Perfusion Before Embolization in Patients With Symptomatic Prostate Adenoma (NCT05389202) | Centre Hospitalier Universitaire de Nīmes | 2022-05-12 |
| Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer (NCT05396872) | University of California, San Francisco | 2022-05-12 |
| Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors (NCT05311618) | NGM Biopharmaceuticals, Inc | 2022-05-11 |
| Retrospective Analysis of 68Ga-PSMA-PET in Patients With Prostate Cancer: Experience From Brazil (NCT05169372) | Latin American Cooperative Oncology Group | 2022-05-11 |
| Social Risk Factors and Discrimination in Cancer Survivorship (NCT05301114) | Medstar Health Research Institute | 2022-05-05 |
| Safety, Tolerability, Distribution & Dose Effect of Neoadjuvant Transarterial Chemoembolization With Doxorubicin in Prostate Cancer Patients Before Radical Prostatectomy (NCT04423913) | Centre Hospitalier Universitaire de Nīmes | 2022-05-04 |
| Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy (HOPE) (NCT05141383) | Institut Curie | 2022-05-04 |
| Pneumatic Compression and Post-induction Hypotension (NCT05343689) | Asan Medical Center | 2022-05-04 |
| PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER) (NCT05269550) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2022-05-03 |
| AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc (NCT05351424) | Columbia University | 2022-05-03 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| Prostate Cancer Screening With Abbreviated MRI Protocol (NCT05603351) | Masaryk Memorial Cancer Institute | 2022-05-01 |
| Comparison of Diagnostic Accuracy of Luminal Index and MP MRI for Accelerated deTEction of Significant Prostate Cancer (NCT05020522) | University College, London | 2022-05-01 |
| The Role of the Seven Sweeps in the Prevention of the Prostate Cancer Among Those With a Positive Family History (NCT05506735) | University of Baghdad | 2022-05-01 |
| PeRsonalizing the Approach to the Oncologic Frail Individual Through Tailored Assessment and Intervention (PROFIT Study) (NCT05319145) | Hospital Universitari Vall d'Hebron Research Institute | 2022-05-01 |
| EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC (NCT05150236) | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 2022-04-29 |
| Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer. (NCT06355843) | The First Affiliated Hospital of Anhui Medical University | 2022-04-28 |
| Observational Study on Extreme Hypofractionation for Localized Prostate Cancer (NCT05344235) | Universitaire Ziekenhuizen KU Leuven | 2022-04-25 |
| Michigan Genetic Hereditary Testing (MiGHT) (NCT05162846) | University of Michigan Rogel Cancer Center | 2022-04-21 |
| Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients (NCT05527483) | University Hospitals Cleveland Medical Center | 2022-04-21 |
| Metastasis-directed Therapy for Oligorecurrent Prostate Cancer (NCT05352178) | Universitaire Ziekenhuizen KU Leuven | 2022-04-20 |
| 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients (NCT05324332) | Peking Union Medical College Hospital | 2022-04-15 |
| RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR) (NCT05176756) | Abramson Cancer Center at Penn Medicine | 2022-04-14 |
| The Man Van Project (NCT06357416) | Royal Marsden NHS Foundation Trust | 2022-04-13 |
| To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors (NCT05253053) | TransThera Sciences (Nanjing), Inc. | 2022-04-13 |
| Home Based Exercise for Patients With Breast or Prostate Cancer (The BENEFIT-CA Study) (NCT05258526) | Hospital de Clinicas de Porto Alegre | 2022-04-07 |
| Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer (NCT05212857) | Fudan University | 2022-04-01 |
| Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer (NCT05245435) | Medical University of Vienna | 2022-04-01 |
| PSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer: a Head to Head, Parallel, Prospective Trial (NCT05297162) | Istituto Clinico Humanitas | 2022-04-01 |
| Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging (NCT04981223) | Stanford University | 2022-04-01 |
| Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors (NCT05215574) | NGM Biopharmaceuticals, Inc | 2022-03-31 |
| Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue (NCT04972097) | Angiodynamics, Inc. | 2022-03-29 |
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors (NCT05252390) | Nuvation Bio Inc. | 2022-03-29 |
| Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology (NCT05354882) | Université Sorbonne Paris Nord | 2022-03-29 |
| 64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer (NCT05286840) | Luke Nordquist, MD | 2022-03-28 |
| Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC) (NCT05348577) | AstraZeneca | 2022-03-25 |
| Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer. (NCT04655365) | CHU de Quebec-Universite Laval | 2022-03-22 |
| MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer (NCT05127850) | University of California, San Francisco | 2022-03-22 |
| Timing of Post-prostatectomy PSMA Imaging (NCT05008900) | University Health Network, Toronto | 2022-03-22 |
| Prostate Imaging Using MRI +/- Contrast Enhancement (NCT04571840) | University College, London | 2022-03-22 |
| Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in High-risk Prostate Cancer Patients Eligible for Robotic-assisted Radical Prostatectomy. (NCT05596851) | European Institute of Oncology | 2022-03-21 |
| PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer (NCT05245006) | Robert Flavell, MD, PhD | 2022-03-18 |
| TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer (NCT05698576) | Urological Research Network, LLC | 2022-03-16 |
| Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer (NCT04926181) | Rahul Aggarwal | 2022-03-16 |
| Evaluation of Fapi-pet in Prostate Cancer. (NCT05192694) | Helsinki University Central Hospital | 2022-03-10 |
| Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer (NCT05081193) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-03-07 |
| PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI (NCT05154162) | Peter MacCallum Cancer Centre, Australia | 2022-03-02 |
| Protons vs. Photons for High-risk Prostate Cancer (NCT05350475) | University of Aarhus | 2022-03-01 |
| The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation (NCT05167175) | Hongqian Guo | 2022-03-01 |
| Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate Cancer (NCT05246774) | Direction Centrale du Service de Santé des Armées | 2022-03-01 |
| Evaluation of Prostate Cancer Margins (NCT05317143) | Intuitive Surgical | 2022-02-22 |
| Validity, Reliability and Minimum Detectable Changes of 2-Minute Walk , Timed Up and Go, Sit and Stand Test in Patients With Prostate Cancer (NCT05195190) | Acibadem University | 2022-02-20 |
| Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions (NCT06126172) | Chang Gung Memorial Hospital | 2022-02-15 |
| Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART) (NCT06546267) | IRCCS San Raffaele | 2022-02-14 |
| 18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients (NCT05141760) | University of Alberta | 2022-02-10 |
| Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Cancer (NCT05533515) | Queen Mary University of London | 2022-02-08 |
| Comparison of Analgesia Efficacy of Transversus Abdominis Plane Block and Posterior Approach Quadratus Lumborum Block (NCT06075498) | Muğla Sıtkı Koçman University | 2022-02-05 |
| A Research for Combination of Prostate Health Index (Phi) and mpMRI PI-RADS in the Diagnosis of Prostate Cancer (NCT05179707) | Qilu Hospital of Shandong University | 2022-02-01 |
| Artificial Intelligence and Radiologists at Prostate Cancer Detection in MRI: The PI-CAI Challenge (NCT05489341) | Radboud University Medical Center | 2022-02-01 |
| Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer (NCT04894188) | National Taiwan University Hospital | 2022-01-27 |
| Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan (NCT05114746) | Novartis Pharmaceuticals | 2022-01-25 |
| First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer (NCT05189457) | H. Lee Moffitt Cancer Center and Research Institute | 2022-01-25 |
| Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer (NCT04319146) | Centre Hospitalier Universitaire de Nice | 2022-01-25 |
| Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors (NCT05313191) | The New York Proton Center | 2022-01-24 |
| FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer (NCT05011188) | Rahul Aggarwal | 2022-01-19 |
| TransPERineal Fusion Biopsy Versus transrECTal (NCT05069584) | GCS Ramsay Santé pour l'Enseignement et la Recherche | 2022-01-17 |
| Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer (NCT05177770) | Coherus Oncology, Inc. | 2022-01-17 |
| A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely (NCT05202301) | Bayer | 2022-01-15 |
| Exercise as Medicine for People With Cancer Sweden (NCT05064670) | Karolinska Institutet | 2022-01-11 |
| CARINAE for Stress Relief in Perioperative Care (NCT05184725) | Adhera Health, Inc. | 2022-01-10 |
| Factors Affecting Androgen Deprivation Therapy Choice in Prostate Cancer Patients (NCT05202340) | Chinese University of Hong Kong | 2022-01-07 |
| The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting. (NCT05010200) | Ashutosh Kumar Tewari | 2022-01-05 |
| Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour (NCT05024162) | Nova Scotia Health Authority | 2022-01-04 |
| Optimizing Positive Predicting Value of Prostate MRI (NCT05078359) | Ospedali Riuniti di Foggia | 2022-01-01 |
| Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer (NCT05249712) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2022-01-01 |
| The Application Research of Ultrasound Guided Puncture Stent Assisted Transperineal Prostate Biopsy (NCT05179720) | Qilu Hospital of Shandong University | 2022-01-01 |
| A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted Surgery (NCT04304079) | Chinese University of Hong Kong | 2022-01-01 |
| Post Marketing Clinical Follow Up of the BioProtect Balloon Implant System (NCT05354440) | BioProtect | 2022-01-01 |